1. bookVolumen 64 (2014): Edición 1 (March 2014)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

High throughput microwell spectrophotometric assay for olmesartan medoxomil in tablets based on its charge-transfer reaction with DDQ

Publicado en línea: 25 Mar 2014
Volumen & Edición: Volumen 64 (2014) - Edición 1 (March 2014)
Páginas: 63 - 75
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. M. Burnier and H. R. Brunner, Angiotensin II receptor antagonists, Lancet 355 (2000) 637-645; DOI: 10.1016/S0140-6736(99)10365-9.10.1016/S0140-6736(99)10365-9Search in Google Scholar

2. G. K. Aulakh, R. K. Sodhi and M. Singh, An update on non-peptide angiotensin receptor antagonists and related RAAS modulators, Life Sci. 81 (2007) 615-639; DOI: 10.1016/j.lfs.2007.06.007.10.1016/j.lfs.2007.06.00717692338Search in Google Scholar

3. P. D. Bari and A. R. Rote, RP-LC and HPTLC methods for the determination of olmesartan medoxomil and hydrochlorothiazide in combined tablet dosage forms, Chromatographia 69 (2009) 1469-1472; DOI: 10.1365/s10337-009-1094-z.10.1365/s10337-009-1094-z270149519568313Search in Google Scholar

4. D. Liu, P. Hu, N. Matsushima, X. Li, L. Li and J. Jiang, Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry, J. Chromatogr. B. 856 (2007) 190-197; DOI: 10.1016/j.jchromb.2007.05.049.10.1016/j.jchromb.2007.05.04917602900Search in Google Scholar

5. V. V. Vaidya, M. N. Roy, S. M. Yetal, S. S. Joshi and S. A. Parekh, LC-MS-MS determination of olmesartan in human plasma. Chromatographia 67 (2008) 174-150; DOI: 10.1365/s10337-007-0453-x.10.1365/s10337-007-0453-xSearch in Google Scholar

6. D. Liu, J. Jiang, P. Wang, S. Feng and P. Hu, Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry, J. Chromatogr. B 878 (2010) 743-748. DOI: 10.1016/j.jchromb.2010. 01.009.Search in Google Scholar

7. R. N. Sharma and S. S. Pancholi, RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions, Acta Pharm. 60 (2010) 13-24. DOI: 10.2478/v10007-010-0010-2.10.2478/v10007-010-0010-220228038Search in Google Scholar

8. N. J. Shah, B. N. Suhagia, R. R. Shah and N. M. Patel, Development and validation of a simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form, Indian J. Pharm. Sci. 69 (2007) 834-836; DOI: 10.4103/0250-474X.58190.10.4103/0250-474X.58190286635320502580Search in Google Scholar

9. C. K. Rao, K. K. Kumar, M. V. Srinivasulu, G. Madhusudhan, K. Mukkanti and K. S. Srinivas, Development and validation of stability-indicating LC method for olmesartan medoxamil, Am. J. Anal. Chem. 3 (2012) 153-160; DOI: 10.4236/ajac.2012.32022.10.4236/ajac.2012.32022Search in Google Scholar

10. C. Mustafa and A. Sacide, Development of a CZE method for the determination of olmesartan medoxomil in tablets, Chromatographia 66 (2007) 929-933; DOI: 10.1365/s10337-007-0424-2.10.1365/s10337-007-0424-2Search in Google Scholar

11. M. Celebier and S. Altinoz, S. Determination of olmesartan medoxomil in tablets by uv-vis spectrophotometry, Pharmazie 62 (2007) 419-422; DOI: 10.1691/ph.2007.6.6233.Search in Google Scholar

12. A. T. Hemke, M. V. Bhure, K. S. Chouhan, K. P. Gupta and S. G. Wadodkar, UV spectrophotometric determination of hydrochlorothiazide and olmesartan medoxomil in pharmaceutical formulation, E-J. Chem. 7 (2010) 1156-1161; DOI: 10.1155/2010/826585.10.1155/2010/826585Search in Google Scholar

13. S. Caglar and A. Onal, Two simple and rapid spectrophotometric methods for the determination of a new antihypertensive drug olmesartan in tablets, J. Anal. Chem. 65 (2010) 239-243; DOI: 10.1134/S1061934810030056.10.1134/S1061934810030056Search in Google Scholar

14. I. A. Darwish, Kinetic spectrophotometric assays for determination of trimetazidine dihydrochloride. Anal. Chim. Acta 551 (2005) 222-231; DOI: 10.1016/j.aca.2005.07.027.10.1016/j.aca.2005.07.027Search in Google Scholar

15. I. A. Darwish, Analytical study for the charge transfer complexes of losartan potassium, Anal. Chim. Acta 549 (2005) 212-220; DOI: 10.1016/j.aca.2005.06.023.10.1016/j.aca.2005.06.023Search in Google Scholar

16. I. A. Darwish, H. A. Abdel-Wadood and N. A. Abdel-Latif, Validated spectrophotometric and fluorimetric assays for analysis of clozapine in tablets and urine, Ann. Chim. 95 (2005) 345-356; DOI: 10.1002/adic.200590039.10.1002/adic.200590039Search in Google Scholar

17. A. T. Fidler, E. L. Baker and R. E. Letz, Neurobehavioural effects of occupational exposure to organic solvents among construction painters, Br. J. Ind. Med. 44 (1987) 292-308; DOI: 10.1136/ oem.44.5.292.Search in Google Scholar

18. H. Wennborg, J. P. Bonde, M. Stenbeck and J. Olsen, Adverse reproduction outcomes among employees working in biomedical research laboratories, Scand. J. Work Environ. Health 28 (2002) 5-11; DOI: 10.5271/sjweh.640.10.5271/sjweh.640Search in Google Scholar

19. H. F. Askal, Spectrophotometric study of the charge transfer complexes of some pharmaceutical butyrophenones, Talanta 44 (1997) 1749-1755; DOI: 10.1016/S0039-9140(97)00043-X.10.1016/S0039-9140(97)00043-XSearch in Google Scholar

20. I. A. Darwish, A. M. Mahmoud and A. A. Al-Majed, A novel analytical approach for reducing the consumption of organic solvents in the charge transfer-based spectrophotometric analysis: application in the analysis of certain antihypertensive drugs, Acta Pharm. 60 (2010) 493-501; DOI: 10.2478/v10007-010-0035-6.10.2478/v10007-010-0035-621169140Search in Google Scholar

21. A. Taha and G. Rücker, Utility of pi-acceptors in alkaloid assay, Arch. Pharm. (Weinheim) 310 (1977) 485-494; DOI: 10.1002/ardp.19773100608.10.1002/ardp.19773100608883878Search in Google Scholar

22. C. Rosendorff, R. Dubiel, J. Xu and K. J. Chavanu, Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy, Am. J. Cardiol. 104 (2009) 359-365; DOI: 10.1016/j.amjcard.2009.03.042.10.1016/j.amjcard.2009.03.04219616668Search in Google Scholar

23. S. G. Chrysant, Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension, Expert Rev. Cardiovasc. Ther. 8 (2009) 887-895; DOI: 10.1586/erc.09.85.10.1586/erc.09.8519673666Search in Google Scholar

24. D. J. Kereiakes, J. M. Neutel, H. A. Punzi, J. Xu, L. J. Lipka and R. Dubiel, Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate, Am. J. Cardiovasc. Drugs 7 (2007) 361-372; DOI: 10.2165/00129784-200707050-00006.10.2165/00129784-200707050-0000617953475Search in Google Scholar

25. S. G. Chrysant, M. A. Weber, A. C. Wang and D. J. Hinman, Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide, Am. J. Hypertens. 17 (2004) 252-259; DOI: 10.1016/j.amjhyper.2003.11.003. 10.1016/j.amjhyper.2003.11.00315001200Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo